CTAG1B and breast cancer: The Kaplan-Meier tool also showed that in DMFS breast cancer patients, overexpressed level of LAGE2B led to poor prognosis in overall survival (HR = 1.55, 95% CI: 1.32–1.83, p for trend = 1 × 10−7, Figure 7A).